We have demonstrated recently a possible mechanism involving proteolytic processing to convert EphA2 into a ligand-insensitive form.9, 10, 11 Membrane type 1-MMP (MT1-MMP) is a membrane MMP that is frequently overexpressed in malignant tumors. This evidence concerns the gene EPHA2 and cancer.